[1]
“Gastrointestinal changes in critical patients with covid-19 receiving enteral nutritional, neuromuscular blockers and/or vasoactive drugs”, Rev. Cont. Saúde, vol. 24, no. 48, p. e13615, Feb. 2024, doi: 10.21527/2176-7114.2024.48.13615.